49 related articles for article (PubMed ID: 38508300)
1. Cholesterol synthesis enzyme SC4MOL is fine-tuned by sterols and targeted for degradation by the E3 ligase MARCHF6.
Qian L; Scott NA; Capell-Hattam IM; Draper EA; Fenton NM; Luu W; Sharpe LJ; Brown AJ
J Lipid Res; 2023 May; 64(5):100362. PubMed ID: 36958722
[TBL] [Abstract][Full Text] [Related]
2. A paREDOX in the control of cholesterol biosynthesis: Does the NADPH sensor and E3 ubiquitin ligase MARCHF6 protect mammalian cells during oxidative stress by controlling sterol biosynthesis?
Fenton NM; Qian L; Paine EG; Sharpe LJ; Brown AJ
Bioessays; 2024 Jul; 46(7):e2400073. PubMed ID: 38760877
[TBL] [Abstract][Full Text] [Related]
3. The cholesterol synthesis enzyme lanosterol 14α-demethylase is post-translationally regulated by the E3 ubiquitin ligase MARCH6.
Scott NA; Sharpe LJ; Capell-Hattam IM; Gullo SJ; Luu W; Brown AJ
Biochem J; 2020 Jan; 477(2):541-555. PubMed ID: 31904814
[TBL] [Abstract][Full Text] [Related]
4. Controlling an E3 ligase and its substrate: A function for MARCHF6 circRNA.
Qian L; Sharpe LJ; Gokool A; Voineagu I; Brown AJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Jan; 1868(1):159237. PubMed ID: 36183995
[No Abstract] [Full Text] [Related]
5. SC5D is the sixth enzyme in cholesterol biosynthesis targeted by the E3 ubiquitin ligase MARCHF6.
Fenton NM; Qian L; Scott NA; Paine EG; Sharpe LJ; Brown AJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2024 May; 1869(4):159482. PubMed ID: 38508300
[No Abstract] [Full Text] [Related]
6. The E3 ubiquitin ligase MARCHF6 as a metabolic integrator in cholesterol synthesis and beyond.
Scott NA; Sharpe LJ; Brown AJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158837. PubMed ID: 33049405
[TBL] [Abstract][Full Text] [Related]
7. Post-translational control of the long and winding road to cholesterol.
Sharpe LJ; Coates HW; Brown AJ
J Biol Chem; 2020 Dec; 295(51):17549-17559. PubMed ID: 33453997
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer.
Sun A; Tian X; Chen Y; Yang W; Lin Q
Pathol Oncol Res; 2023; 29():1610931. PubMed ID: 36825281
[TBL] [Abstract][Full Text] [Related]
9. Structural Diversity of Ubiquitin E3 Ligase.
Toma-Fukai S; Shimizu T
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771091
[TBL] [Abstract][Full Text] [Related]
10. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy.
Sampson C; Wang Q; Otkur W; Zhao H; Lu Y; Liu X; Piao HL
Clin Transl Med; 2023 Mar; 13(3):e1204. PubMed ID: 36881608
[TBL] [Abstract][Full Text] [Related]
11. Regulation of E3 ubiquitin ligases by homotypic and heterotypic assembly.
Balaji V; Hoppe T
F1000Res; 2020; 9():. PubMed ID: 32076548
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
